Skip to main content

Chagas Disease in Europe

  • Chapter
  • First Online:
Chagas Disease

Abstract

Chagas disease is an infectious disease caused by the parasite Trypanosoma cruzi. It affects approximately seven million people worldwide, most of them in Latin America, where insect vectors that transmit the infection are endemic. Besides, T. cruzi can also be transmitted through blood transfusion, organ transplant, and from mother to child. The infection is chronic in a majority of cases and remains asymptomatic for years. It is estimated that ~30% of those chronically infected will end up developing the life-threatening symptoms characteristic of the disease: heart and/or gastrointestinal tract tissue disruptions. In the last decades, large migratory flows between Latin American countries and non-endemic regions like Europe have spread Chagas disease impact. Its silent clinical progression and vector-independent transmission routes entail a health challenge in non-endemic countries too. In this chapter we present the epidemiological status of Chagas disease in Europe as well as the measures being taken to downsize its public health risk and to control the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yépez del Castillo I. Las migraciones entre América Latina y Europa: una dimensión de las relaciones entre estas dos regiones. In: Yépez del Castillo I, Herrera G, editors. Nuevas migraciones latinoamericanas a Europa. Balances y desafíos. Quito: Biblioteca FLACSO; 2007. p. 19–30.

    Google Scholar 

  2. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115:22–7.

    Article  PubMed  Google Scholar 

  3. López de Lera D, Oso Casas L. La inmigración latinoamericana en España. Tendencias y estado de la cuestión. In: Yépez del Castillo I, Herrera G, editors. Nuevas migraciones latinoamericanas a Europa. Balances y desafíos. Quito: Biblioteca FLACSO; 2007. p. 31–68.

    Google Scholar 

  4. Roca C, Pinazo MJ, López-Chejade P, Bayó J, Posada E, López-Solana J, Gállego M, Portús M, Gascón J. Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain. PLoS Negl Trop Dis. 2011;5:e1135.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jackson Y, Chappuis F. Chagas disease in Switzerland: history and challenges. Euro Surveill. 2011;16:pii 19963.

    Google Scholar 

  6. Angheben A, Anselmi M, Gobbi F, et al. Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill. 2011;16:pii 19969.

    Google Scholar 

  7. Jackson Y, Herrera MV, Gascon J. Economic crisis and increased immigrant mobility: new challenges in managing Chagas disease in Europe. Bull World Health Organ. 2014;92:771–2.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Requena-Méndez A, Aldasoro E, de Lazzari E, Sicuri E, Brown M, Moore DAJ, Gascon J, Muñoz J. Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9:e0003540.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Jannin J, Salvatella R. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Organización Panamericana de la Salud; OPS/HDM/CD/425-06. Geneva: Department of Control of Neglecled Tropical Diseases (NTD). Innovative and Intensified Disease Management (IDM). WHO/NTD/IDM; 2006.

    Google Scholar 

  10. WHO. Control and prevention of Chagas disease in Europe. Issue December 2009; 69 p.

    Google Scholar 

  11. Basile L, Jansa JM, Carlier Y, et al. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16:pii 19968.

    Article  Google Scholar 

  12. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14–21.

    Article  PubMed  Google Scholar 

  13. Requena-Méndez A, Moore DAJ, Subirà C, Muñoz J. Addressing the neglect: Chagas disease in London, UK. Lancet Glob Heal. 2016;4:e231–3.

    Article  Google Scholar 

  14. Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas’ disease in the United States. Clin Microbiol Rev. 2011;24:655–81.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gascon J, Pinazo MJ. Chagas disease: from Latin America to the world. Re Parasitol. 2015;2015:7–14.

    Article  Google Scholar 

  16. Villalba R, Fornes G, Alvarez MA, Roman J, Rubio V, Fernandez M, Garcia JM, Vinals M, Torres A. Acute Chagas’ disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis. 1992;14:594–5.

    Article  CAS  PubMed  Google Scholar 

  17. Forés R, Sanjuán I, Portero F, et al. Chagas disease in a recipient of cord blood transplantation. Bone Marrow Transplant. 2007;39:127–8.

    Article  PubMed  Google Scholar 

  18. Valls FV, Puy RV, Bassany EE, Cano ML, Sánchez JL, Lozoya R, Azem J, Naval X, Armengol M. Caso clínico de enfermedad de Chagas transfusional. Emf Emerg. 2008;10(Suppl 1):14–8.

    Google Scholar 

  19. Rodriguez-Guardado A, González ML, Rodriguez M, Flores-Chavez M, Boga JA, Gascon J. Trypanosoma cruzi infection in a Spanish liver transplant recipient. Clin Microbiol Infect. 2015;21:687.

    Article  PubMed  Google Scholar 

  20. Piron M, Vergés M, Muñoz J, et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion. 2008;48:1862–8.

    Article  PubMed  Google Scholar 

  21. El Ghouzzi MH, Boiret E, Wind F, Brochard C, Fittere S, Paris L, Mazier D, Sansonetti N, Bierling P. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion. 2010;50:575–83.

    Article  PubMed  Google Scholar 

  22. Gabrielli S, Girelli G, Vaia F, Santonicola M, Fakeri A, Cancrini G. Surveillance of Chagas disease among at-risk blood donors in Italy: preliminary results from Umberto I Polyclinic in Rome. Blood Transfus. 2013;11:558–62.

    PubMed  PubMed Central  Google Scholar 

  23. Slot E, Hogema BM, Molier M, Bart A, Zaaijer HL. Risk factors and screening for Trypanosoma cruzi infection of Dutch blood donors. PLoS One. 2016;11:e0151038.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Martinez de Tejada B, Jackson Y, Paccolat C, Irion O. Congenital Chagas disease in Geneva: diagnostic and clinical aspects. Rev Méd Suisse. 2009;5:2091–2–4–6.

    Google Scholar 

  25. Muñoz-Vilches MJ, Salas J, Cabezas T, Metz D, Vázquez J, Soriano MJ. Chagas screening in pregnant Latin-American women. Experience in Poniente Almeriense (Almeria, Spain). Enferm Infecc Microbiol Clin. 2012;30:380–2.

    Article  PubMed  Google Scholar 

  26. Paricio-Talayero JM, Benlloch-Muncharaz MJ, Collar-del-Castillo JI, et al. Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community. Enferm Infecc Microbiol Clin. 2008;26:609–13.

    Article  PubMed  Google Scholar 

  27. Muñoz J, Coll O, Juncosa T, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009;48:1736–40.

    Article  PubMed  Google Scholar 

  28. Francisco-González L, Gastañaga-Holguera T, Jiménez Montero B, Daoud Pérez Z, Illán Ramos M, Merino Amador P, Herráiz Martínez MÁ, Ramos Amador JT. Seroprevalencia y transmisión vertical de enfermedad de Chagas en una cohorte de gestantes latinoamericanas en un hospital terciario de Madrid. An Pediatr (Barc). 2018;88:122. pii: S1695-4033(17)30148-0.

    Article  Google Scholar 

  29. Barona-Vilar C, Gimenez-Marti MJ, Fraile T, et al. Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain). Epidemiol Infect. 2012;140:1896–903.

    Article  CAS  PubMed  Google Scholar 

  30. Jackson Y, Myers C, Diana A, Marti HP, Wolff H, Chappuis F, Loutan L, Gervaix A. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis. 2009;15:601–3.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Muñoz J, Portús M, Corachan M, Fumadó V, Gascon J. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg. 2007;101:1161–2.

    Article  PubMed  Google Scholar 

  32. Riera C, Guarro A, El Kassab H, et al. Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am J Trop Med Hyg. 2006;75:1078–81.

    Article  PubMed  Google Scholar 

  33. Roura M, Domingo A, Leyva-Moral JM, Pool R. Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review. BMC Public Health. 2015;15:472.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Egüez KE, Alonso-Padilla J, Terán C, Chipana Z, García W, Torrico F, Gascon J, Lozano-Beltran D-F, Pinazo M-J. Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis. PLoS Negl Trop Dis. 2017;11:e0005501.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Piron M, Fisa R, Casamitjana N, López-Chejade P, Puig L, Vergés M, Gascón J, Gómez i Prat J, Portús M, Sauleda S. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop. 2007;103:195–00.

    Article  CAS  PubMed  Google Scholar 

  36. Seiringer P, Pritsch M, Flores-Chavez M, et al. Comparison of four PCR methods for efficient detection of Trypanosoma cruzi in routine diagnostics. Diagn Microbiol Infect Dis. 2017;88:225–32.

    Article  CAS  PubMed  Google Scholar 

  37. Abras A, Muñoz C, Ballart C, et al. Towards a new strategy for diagnosis of congenital Trypanosoma cruzi infection. J Clin Microbiol. 2017;55:1396–07.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Abras A, Llovet T, Tebar S, Herrero M, Berenguer P, Ballart C. Serological diagnosis of chronic Chagas disease: is it time for a change? J Clin Microbiol. 2016;54:1566–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. ISGlobal site. Barcelona’s Bolivian community spreads the word about Chagas disease. 2016. http://www.isglobal.org/en/-/la-comunidad-boliviana-en-barcelona-pasa-la-voz-contra-el-chagas. Accessed 10 Nov 2017.

  40. Navarro M, de los Santos JJ. Access to Chagas disease treatment in non-endemic countries: the case of Spain. Lancet Glob Health. 2017;5:e577.

    Article  PubMed  Google Scholar 

  41. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA. 2007;298:2171–81.

    Article  CAS  PubMed  Google Scholar 

  42. Alvarez MG, Vigliano C, Lococo B, Bertocchi G, Viotti R. Prevention of congenital Chagas disease by benznidazole treatment in reproductive-age women. An observational study. Acta Trop. 2017;174:149–52.

    Article  CAS  PubMed  Google Scholar 

  43. Fabbro DL, Danesi E, Olivera V, Codebó MO, Denner S, Heredia C, Streiger M, Sosa-Estani S. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014;8:e3312.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Viotti R, Alarcón De Noya B, Araujo-Jorge T, et al. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother. 2014;58:635–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. DNDi site. Paediatric dosage form of benznidazole (Chagas). https://www.dndi.org/diseases-projects/portfolio/paediatric-benznidazole/. Accessed 15 Nov 2017.

  46. MundoSano site. An Argentine laboratory will develop the pediatric formula for Chagas disease treatment. https://www.mundosano.org/en/an-argentine-laboratory-will-develop-the-pediatric-formula-for-chagas-disease-treatment/. Accessed 15 Nov 2017.

  47. Wagner N, Jackson Y, Chappuis F, Posfay-Barbe KM. Screening and management of children at risk for Chagas disease in nonendemic areas. Pediatr Infect Dis J. 2016;35:335–7.

    Article  PubMed  Google Scholar 

  48. Pinazo MJ, Muñoz J, Posada E, López-Chejade P, Gállego M, Ayala E, del Cacho E, Soy D, Gascon J. Tolerance of benznidazole in treatment of Chagas’ disease in adults. Antimicrob Agents Chemother. 2010;54:4896–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Sperandio da Silva GM, Felix Mediano MF, Hasslocher-Moreno AM, et al. Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas’ disease. J Antimicrob Chemother. 2017;72:2596–601.

    Article  PubMed  Google Scholar 

  50. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2013;381:1235–45.

    Article  PubMed  Google Scholar 

  51. Pinazo MJ, Cañas E, Elizalde JI, et al. Diagnosis, management and treatment of chronic Chagas’ gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic. Gastroenterol Hepatol. 2010;33:191–00.

    Article  PubMed  Google Scholar 

  52. Gascon J, Albajar P, Canas E, et al. Diagnosis, management and treatment of chronic Chagas’ heart disease in areas where Trypanosoma cruzi infection is not endemic. Enferm Infecc Microbiol Clin. 2008;26:99–106.

    Article  PubMed  Google Scholar 

  53. González-Tomé MI, Rivera M, Camaño I, et al. Recommendations for the diagnosis, treatment and follow-up of the pregnant woman and child with Chagas disease. Enferm Infecc Microbiol Clin. 2013;31:535–42.

    Article  PubMed  Google Scholar 

  54. Roca Saumell C, Soriano-Arandes A, Solsona Díaz L, Gascón Brustenga J. Consensus document for the detection and management of Chagas disease in primary health care in a non-endemic areas. Aten Primaria. 2015;47:308–17.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Pérez-Molina J, Rodríguez-Guardado A, Soriano A, et al. Guidelines on the treatment of chronic coinfection by Trypanosoma cruzi and HIV outside endemic areas. HIV Clin Trials. 2011;12:287–98.

    Article  PubMed  Google Scholar 

  56. Pinazo MJ, Miranda B, Rodríguez-Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev. 2011;25:91–101.

    Article  Google Scholar 

  57. Repetto EC, Zachariah R, Kumar A, et al. Neglect of a neglected disease in Italy: the challenge of access-to-care for Chagas disease in Bergamo area. PLoS Negl Trop Dis. 2015;9:e0004103.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Ministerio de Sanidad y Consumo. Real Decreto 1088/2005. Boletín Oficial del Estado. 2005. pp. 31288–304.

    Google Scholar 

  59. National Blood Service. Guidelines for the blood services in the United Kingdom. 2005.

    Google Scholar 

  60. Ministère de la Santé et des Sports. Arrêté du 12 janvier 2009 fixant les critères de sélection des donneurs de sang. NOR: SJSP0901086A.

    Google Scholar 

  61. Ministerio della Salute. Protocolli per l’accertamento della idoneita del donatore di sangue e di emocomponenti. GU n.85 del 13-04-2005. 2005. https://infoleges.it. Accessed 5 Nov 2017.

  62. Källstrand Nord E. Socialstyrelsens författningssamling. SOSFS 2009:28 (M).

    Google Scholar 

  63. Directiva 2010/45/UE. Diario Oficial de la Unión Europea. 2010; 1–8.

    Google Scholar 

  64. Criteri generali per la valutazione di idoneita del donatore. Allegato E. Centro Nazionale Trapanti. 9 Agosto 2012.

    Google Scholar 

  65. Ministerio de Sanidad, Servicios Sociales e Igualdad. Real Decreto 1732/2012. Boletín Oficial del Estado. pp. 89315–48.

    Google Scholar 

  66. Criterios de Selección de donantes de órganos respecto a la transmisión de infecciones. 2004. Organización Nacional de Trasplantes. 2ª Ed. pp. 1–37.

    Google Scholar 

  67. Sicuri E, Muñoz J, Pinazo MJ, Posada E, Sanchez J, Alonso PL, Gascon J. Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Trop. 2011;118:110–7.

    Article  PubMed  Google Scholar 

  68. Protocol de cribatge i diagnòstic de malaltia de Chagas en dones embarassades llatinoamericanes i en els seus nadons. Planificació i avaluació Salut Pública - Protocol Chagas. Departamente de Salut. Generalitat de Catalunya. 2010.

    Google Scholar 

  69. Regulación del control de las infecciones congénitas y perinatales en la Comunidad Valenciana. Circ. 3/2007/8/1. Conselleria de Sanitat de la Comunitat Valenciana. 2007.

    Google Scholar 

  70. Programma regionale per la prevenzione e il controllo della malattia di Chagas congenita: indicazione per l’assistenza in gravidanza. Delibera Regione Toscana n. 489 del 04/0672012.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joaquim Gascón .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alonso-Padilla, J., Pinazo, M.J., Gascón, J. (2019). Chagas Disease in Europe. In: Altcheh, J., Freilij, H. (eds) Chagas Disease. Birkhäuser Advances in Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-00054-7_5

Download citation

Publish with us

Policies and ethics